Page last updated: 2024-09-03

fk 633 and Coronary Disease

fk 633 has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asanuma, H; Hori, M; Imakita, M; Imamura, E; Ishibashi-Ueda, H; Kitakaze, M; Kuzuya, T; Minamino, T; Ozaki, T; Ueda, Y	1

Other Studies

1 other study(ies) available for fk 633 and Coronary Disease

Article	Year
Glycoprotein IIb/IIIa antagonist FK633 could not prevent neointimal thickening in stent implantation model of canine coronary artery. Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:2 Topics: Animals; Coronary Disease; Coronary Vessels; Dipeptides; Dogs; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Stents; Tunica Intima	1999

Article

Year

Glycoprotein IIb/IIIa antagonist FK633 could not prevent neointimal thickening in stent implantation model of canine coronary artery.

Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:2

Topics: Animals; Coronary Disease; Coronary Vessels; Dipeptides; Dogs; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Stents; Tunica Intima

1999